About
History
Executed a Letter of Intent (LOI) with Kaiser Permanente
Signed a contract to supply an integrated digital pathology IMS (MeDiAuto) solution to Seoul St. Mary's Hospital
Participated in KHF 2025
Exhibited at HLTH USA 2025
Selected for the Techstars MAPMG healthcare acceleration program in the U.S.
Selected for the TIPS R&D Global Track program (through 2028)
Participated in the Digital Pathology Association Symposium and operated a booth
Secured follow-on investment from The Invention Lab
Executed a national biohealth big data advancement and digital medical device development project (through 2028)
Executed a digital pathology-based data construction project for spatial biomarker development
Secured additional investment from The Invention Lab and other investors
Co-founded the Digital Pathology Association with senior pathologists
Obtained GMP Grade 2 certification for Software as a Medical Device (SaMD)
Signed an MOU with Aiforia, a Finnish medical AI solutions provider
Secured strategic investment from Naver Cloud
Executed a public healthcare digital pathology transformation project (through 2025)
Exhibited at CES 2024
Selected for an NIA training data construction project in uropathology
Participated in Korea’s largest national AI competition hosted by the Ministry of Science and ICT
Participated in a National Cancer Center-led personalized healthcare research project for cancer survivors (through 2025)
Executed a platform development project for autism spectrum disorder diagnosis (through 2024)
Executed an AI-based digital pathology platform project for cancer diagnosis (through 2025)
Established as a technology research corporation in collaboration with ETRI
An AI-powered healthcare platform,
creating new value
for the future of humanity.
Solution Inquiry
